Pancreatic Cancer Research

ResearcherSynapse (Netherlands)Active in the last 2 years

Mark Roest

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7349-7068; OpenAlex author ID A5103113015. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 4

  1. Plasmin Generation Kinetics Reveal a Hyperfibrinolytic Phenotype in Patients with Pancreatic Ductal Adenocarcinoma Last author DOI 10.1055/a-2925-6824↗
  2. Altered whole blood thrombin generation and hyperresponsive platelets in patients with pancreatic cancer. Last author DOI 10.1016/j.jtha.2023.12.037↗
  3. Cellular Components Contributing to the Development of Venous Thrombosis in Patients with Pancreatic Cancer. Co-author DOI 10.1055/s-0043-1777304↗
  4. Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care. Co-author DOI 10.3390/cancers15143546↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ruth A.L. Willems · 4 shared papers, 2023–2026 · strength 0.86
  2. Hugo ten Cate an · 4 shared papers, 2023–2026 · strength 0.86
  3. Judith de Vos‐Geelen · 4 shared papers, 2023–2026 · strength 0.86
  4. Dana Huskens · 2 shared papers, 2024–2026 · strength 0.47
  5. Elena Campello · 1 shared paper, 2024 · strength 0.23
  6. Paolo Simioni · 1 shared paper, 2024 · strength 0.23
  7. Nick van Es · 1 shared paper, 2023 · strength 0.15
  8. Johanna W. Wilmink · 1 shared paper, 2023 · strength 0.15
  9. Merlijn U.J.E. Graus · 1 shared paper, 2023 · strength 0.15
  10. Nynke Michiels · 1 shared paper, 2023 · strength 0.15
  11. Stefan A.W. Bouwense · 1 shared paper, 2023 · strength 0.15
  12. Bas Groot Koerkamp · 1 shared paper, 2023 · strength 0.15
  13. J. Sven D. Mieog · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.